SOLV vs. ELV
SOLV (Solventum Corp) and ELV (Elevance Health Inc) are both stocks. Both are in the Healthcare sector — SOLV in Medical Instruments & Supplies, ELV in Healthcare Plans. Over the past year, SOLV returned 5.52% vs 5.45% for ELV. At a 0.21 correlation, their price movements are largely independent.
Performance
SOLV vs. ELV - Performance Comparison
Loading charts...
Returns By Period
In the year-to-date period, SOLV achieves a -1.11% return, which is significantly lower than ELV's 12.30% return.
SOLV
- 1D
- 2.53%
- 1M
- 16.19%
- YTD
- -1.11%
- 6M
- -8.08%
- 1Y
- 5.52%
- 3Y*
- —
- 5Y*
- —
- 10Y*
- —
ELV
- 1D
- 0.58%
- 1M
- 5.21%
- YTD
- 12.30%
- 6M
- 19.64%
- 1Y
- 5.45%
- 3Y*
- -4.47%
- 5Y*
- 1.32%
- 10Y*
- 13.06%
SOLV vs. ELV - Yearly Performance Comparison
| 2026 (YTD) | 2025 | 2024 | |
|---|---|---|---|
SOLV Solventum Corp | -1.11% | 19.95% | -17.43% |
ELV Elevance Health Inc | 12.30% | -3.14% | -27.95% |
Correlation
The correlation between SOLV and ELV is 0.22, which is low. Their price movements are largely independent, making them effective diversification partners.
| Correlation | |
|---|---|
Correlation (1Y) Calculated over the trailing 1-year period | 0.22 |
Correlation (All Time) Calculated using the full available price history since Mar 27, 2024 | 0.21 |
Fundamentals
SOLV:
$13.75B
ELV:
$86.24B
SOLV:
$8.17
ELV:
$23.46
SOLV:
9.60
ELV:
16.68
SOLV:
1.66
ELV:
0.44
SOLV:
2.77
ELV:
1.96
SOLV:
$8.26B
ELV:
$200.42B
SOLV:
$4.43B
ELV:
$46.43B
SOLV:
$2.62B
ELV:
$8.92B
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Return for Risk
SOLV vs. ELV — Risk / Return Rank
SOLV
ELV
SOLV vs. ELV - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for Solventum Corp (SOLV) and Elevance Health Inc (ELV). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
| SOLV | ELV | Difference | |
|---|---|---|---|
| Sharpe ratioReturn per unit of total volatility | +0.06 | ||
| Sortino ratioReturn per unit of downside risk | +0.06 | ||
| Omega ratioGain probability vs. loss probability | 1.06 | 1.07 | -0.01 |
| Calmar ratioReturn relative to maximum drawdown | 0.20 | 0.18 | +0.02 |
| Martin ratioReturn relative to average drawdown | 0.46 | 0.33 | +0.14 |
Data is calculated on a 1-year rolling basis and updated daily. The trend shows the change in the indicator over the past month. | |||
Loading charts...
Sharpe Ratios by Period
| SOLV | ELV | Difference | |
|---|---|---|---|
Sharpe Ratio (1Y)Calculated over the trailing 1-year period | 0.21 | 0.14 | +0.06 |
Sharpe Ratio (5Y)Calculated over the trailing 5-year period | — | 0.05 | — |
Sharpe Ratio (10Y)Calculated over the trailing 10-year period | — | 0.43 | — |
Sharpe Ratio (All Time)Calculated using the full available price history | -0.03 | 0.45 | -0.48 |
Drawdowns
SOLV vs. ELV - Drawdown Comparison
The maximum SOLV drawdown since its inception was -39.97%, smaller than the maximum ELV drawdown of -67.19%. Use the drawdown chart below to compare losses from any high point for SOLV and ELV.
Loading charts...
Drawdown Indicators
| SOLV | ELV | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -39.97% | -67.19% | +27.22% |
Max Drawdown (1Y)Largest decline over 1 year | -27.46% | -30.60% | +3.14% |
Max Drawdown (3Y)Largest decline over 3 years | — | -50.38% | — |
Max Drawdown (5Y)Largest decline over 5 years | — | -50.38% | — |
Max Drawdown (10Y)Largest decline over 10 years | — | -50.38% | — |
Current DrawdownCurrent decline from peak | -9.03% | -28.12% | +19.09% |
Average DrawdownAverage peak-to-trough decline | -15.48% | -15.29% | -0.19% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 11.97% | 16.76% | -4.79% |
Volatility
SOLV vs. ELV - Volatility Comparison
The current volatility for Solventum Corp (SOLV) is 6.25%, while Elevance Health Inc (ELV) has a volatility of 7.28%. This indicates that SOLV experiences smaller price fluctuations and is considered to be less risky than ELV based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Loading charts...
Volatility by Period
| SOLV | ELV | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | 6.25% | 7.28% | -1.03% |
Volatility (6M)Calculated over the trailing 6-month period | 20.13% | 26.88% | -6.75% |
Volatility (1Y)Calculated over the trailing 1-year period | 26.77% | 38.29% | -11.52% |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 31.79% | 28.86% | +2.93% |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 31.79% | 30.80% | +0.99% |
Dividends
SOLV vs. ELV - Dividend Comparison
SOLV has not paid dividends to shareholders, while ELV's dividend yield for the trailing twelve months is around 1.75%.
| Position | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
ELV Elevance Health Inc | 1.75% | 1.95% | 1.77% | 1.26% | 1.00% | 0.98% | 1.18% | 1.06% | 1.14% | 1.20% | 1.81% | 1.79% |
SOLV Solventum Corp | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
Financials
SOLV vs. ELV - Financials Comparison
This section allows you to compare key financial metrics between Solventum Corp and Elevance Health Inc. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.
Total Revenue: Total amount of money received from sales and other business activities
SOLV vs. ELV - Profitability Comparison
SOLV - Gross Margin
Gross margin is calculated as gross profit divided by revenue. For the three months ending on Jun 2026, Solventum Corp reported a gross profit of 1.10B and revenue of 2.01B. Therefore, the gross margin over that period was 54.7%.
ELV - Gross Margin
Gross margin is calculated as gross profit divided by revenue. For the three months ending on Jun 2026, Elevance Health Inc reported a gross profit of 9.10B and revenue of 50.18B. Therefore, the gross margin over that period was 18.1%.
SOLV - Operating Margin
Operating margin is calculated as operating income divided by revenue. For the three months ending on Jun 2026, Solventum Corp reported an operating income of 81.00M and revenue of 2.01B, resulting in an operating margin of 4.0%.
ELV - Operating Margin
Operating margin is calculated as operating income divided by revenue. For the three months ending on Jun 2026, Elevance Health Inc reported an operating income of 2.66B and revenue of 50.18B, resulting in an operating margin of 5.3%.
SOLV - Net Margin
Net margin is calculated as net income divided by revenue. For the three months ending on Jun 2026, Solventum Corp reported a net income of 13.00M and revenue of 2.01B, resulting in a net margin of 0.7%.
ELV - Net Margin
Net margin is calculated as net income divided by revenue. For the three months ending on Jun 2026, Elevance Health Inc reported a net income of 1.76B and revenue of 50.18B, resulting in a net margin of 3.5%.
Frequently Asked Questions
SOLV and ELV have a correlation of 0.22, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.
ELV has higher volatility (7.28%) compared to SOLV (6.25%). In terms of maximum drawdown, SOLV dropped -39.97% vs ELV's -67.19%.
SOLV currently has the higher Sharpe Ratio (0.21 vs 0.14), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.
Find the right allocation for SOLV and ELV
Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.
Open Portfolio Optimizer